securities fraud

Class action lawsuit filed against Corcept Therapeutics for allegedly making false claims about relacorilant drug's clinical strength while concealing FDA regulatory concerns.

Class action filed against $SDM alleging market manipulation, social media fraud, and insider share dumping. Lead plaintiff deadline March 16, 2026.

Class action filed against Mereo BioPharma over allegedly false statements regarding failed Phase 3 clinical trials, covering $MREO investors from June 2023 to December 2025.

Schall Law Firm seeks investors in $RGNX securities fraud class action over allegedly misleading statements about RGX-111 clinical trial data.

Class action lawsuit filed against $QURE over alleged misstatements about AMT-130 gene therapy FDA approval status. Stock plunged 49% after FDA reversed position on Phase I/II data adequacy.

Schall Law Firm launches class action against $KD over alleged false statements and financial reporting failures affecting investors from August 2024 to February 2026.

Schall Law Firm files securities fraud class action against $INO for allegedly making false statements about manufacturing deficiencies and regulatory filing timelines.

Portnoy Law Firm investigates Baidu for potential securities fraud after Pentagon linked it to Chinese military. Stock fell 1.3% to $116.34 on November 26, 2025.

Trip.com stock plummets 18% after China's antitrust regulator launches investigation; U.S. law firm files securities fraud claim citing inadequate disclosure.

Law firm investigates Trip.com for potential securities fraud after 18% stock plunge following China's antitrust notice.

Zimmer Biomet stock fell 15.2% after cutting organic revenue guidance to 4.0% from 4.5%, citing emerging market weakness and U.S. revision slowdown. Securities investigation launched.

Alight stock crashed 38.2% after disappointing Q4 2025 results. Law firm investigates potential securities violations as investors assess damage.

Rosen Law Firm investigates potential securities claims against $VITL following 10.8% stock drop on disappointing earnings. Class action lawsuits being prepared.

Class action lawsuit filed against $CLEUF for allegedly coordinating pump-and-dump scheme with scammers, causing $300M investor losses after stock collapse.

PennyMac Financial Services ($PFSI) stock crashed 33% after revealing servicing income fell 76% quarter-over-quarter, prompting securities investigation.

Law firm Levi & Korsinsky files class action against Boston Scientific, citing misleading statements. Stock tumbled 17.6% after disappointing Q4 2025 earnings and weak 2026 guidance.

Class action lawsuit filed against $RR after stock plunges on allegations of false Microsoft partnership claims. Investors can join through April 3.

Pomerantz LLP investigates KDDI Corporation following earnings postponement tied to internal probe. Stock fell 11.44% to $15.71.

Pomerantz Law Firm sued China Liberal Education Holdings for alleged pump-and-dump fraud via social media manipulation, with $CLEUF stock collapsing January 30, 2025. Class action deadline: March 31, 2026.

Enphase Energy faces class action lawsuit over alleged misstatements on inventory management and tax credit impacts. Lead plaintiff deadline: April 20, 2026.